Shaimaa Elshafie

8PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 30, 2026
Concurrent Antidepressant Use and Metastasis Risk Among Women Receiving Tamoxifen for Breast Cancer: A Real-World Cohort Study.

|Aug 31, 2026
Immunosuppressive medication exposure and risk of invasive fungal and nontuberculous mycobacterial infections following TNF-α inhibitor initiation: a time-varying analysis.

|Dec 31, 2024
Cardiovascular and Metabolic Adverse Events of Endocrine Therapies in Women with Breast Cancer: A Disproportionality Analysis of Reports in the FDA Adverse Event Reporting System.

Shaimaa Elshafie, Lorenzo Villa-Zapata, Randall L Tackett

|Sep 05, 2024
Adherence, clinical benefits, and adverse effects of endocrine therapies among women with nonmetastatic breast cancer in developing countries: A systematic review and meta-analysis.

Shaimaa Elshafie, Rupal Trivedi, Lorenzo A Villa-Zapata

|Feb 16, 2024
Effectiveness and Feasibility of Telehealth-Based Dietary Interventions Targeting Cardiovascular Disease Risk Factors: Systematic Review and Meta-Analysis.

Rupal Trivedi, Shaimaa Elshafie, Randall Tackett

|Jun 09, 2022
Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis.

Shaimaa Elshafie, Rupal Trivedi-Kapoor, Mark Ebell

Pageof 2

Frequent Collaborators

3 joint publications

Lorenzo Villa-Zapata

2 joint publications

Rupal Trivedi-Kapoor

2 joint publications

Mohammed Zuber

1 joint publications

Randall Tackett